Audit of Platelets Usage among Patients: A Descriptive Study of Various Platelet Concentrates
Journal Title: International Blood Research & Reviews - Year 2016, Vol 6, Issue 4
Abstract
Background: Transfusion services are aimed to provide only those components which patients require and keep the rest for others. Platelet transfusion is critical due to lack of alternative; and therefore should be used rationally. Aim: To elucidate the rational use of different platelet concentrates, its comparative efficacy in thrombocytopenia patients at our tertiary care hospital. Materials and Methods: This prospective cross-sectional two-year study was carried out at a tertiary care hospital in India. Relevant clinical findings, pre/post transfusion platelet count along with complete haemogram and diagnosis of patients were considered in compiling the data. Quality of Platelet was maintained as per the standard protocol of American Association of Blood Bank (AABB). Results: Total 4157 units of platelet concentrates from recruited donors were prepared, where 3483 (83.97%) units were utilized and 674 (16.21%) were unfit for transfusion. 3483 fit Platelet concentrates were transfused to 1225 patients. Out of 3483 transfusions, 1080(31%) were therapeutic and 2403(69%) were prophylactic. In the study 3104 Random Donor Platelet (RDP) and 379 Single Donor Platelets (SDP) were transfused to 978 and 247 patients respectively. Mean absolute increase in platelet count was 4.8x109/L (SD= 2.9x109/L) for RDP and for SDP it was 33.2x109/L (SD=6.0x109/L). Out of 3483 platelets transfusion, about 80% were found to be rational according to British Committee for Standards in Haematology (BCSH) criteria. Conclusion: A healthy rationality of 80% was observed in the present study. Platelet concentrates should be used rationally and scientifically as per proven criteria because it has no alternative.
Authors and Affiliations
Dharmesh Chandra Sharma, Lokesh Tripathi, Poonam Woike, Sunita Rai, Rajesh Gaur
Keywords
Related Articles
- EP ID EP242767
- DOI 10.9734/IBRR/2016/29327
- Views 139
- Downloads 0
AML with Additional Cytogenetic Abnormalities to t(8: 21) has Poorer Survival than that with Isolated t(8;21): A Retrospective Multicenter Cohort Study
Aim of the Study: To investigate the poor prognostic factors incriminated in AML with t (8; 21), particularly additional cytogenetic findings, clinicopathological presentation and their impact on survival rate in Egyptia...
Combined Closed-circuit Acute Normovolemic Hemodilution and Deliberate Hypotension in a Jehovah’s Witness: A Case Report
Aims: To enlighten both clinicians and Jehovah’s Witness patients on closed-circuit acute normovolemic hemodilution (ANH) and deliberate hypotension (DH) as safe and acceptable blood conservation strategies. Case Present...
Immunological and Hematological Profile of HIV Patients on Anti-retroviral Therapy in Port Harcourt, Rivers State, Nigeria
Aims: To profile CD4 count, TNFα levels and cytopenia in HIV seropositive patients on ART and also evaluate the prevalence of hematological cytopenia. Study Design: The present study is a cross sectional study and was c...
Calotropis procera Extract Halts Plasmodium falciparum Transgression Through Red Blood Cell (RBC) Membrane
Aim: To evaluate the potential of Calotropis procera extracts in erythrocyte membrane stabilization with special emphasis on Plasmodium falciparum entry into RBCs. Place and Duration of Study: Department of Zoology, BMT...
Haematological Changes Associated With Hepatitis E Virus Seropositivity among Human and Animal Subjects in Plateau State, Nigeria
Aim: To investigate the haematological manifestations of Hepatitis E Virus (HEV) seropositivity. Study Design: Cross sectional study. We included 592 subjects in the study; (426 humans and 166 animals). Humans were cate...